Skip to main content
Log in

Chemotherapy as first line treatment for oligodendroglioma

  • Letter to the editor
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Sunyach MP, Jouvet A, Perol D, Jouanneau E, Guyotat J, Gignoux L et al (2007) Role of exclusive chemotherapy as first line treatment in oligodendroglioma. J Neurooncol Jun 14; [Epub ahead of print]

  2. Puduvalli VK, Hashmi M, McAllister LD, Levin VA, Hess KR, Prados M et al (2003) Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival. Oncology 65(3):259–266

    Article  PubMed  Google Scholar 

  3. Intergroup Radiation Therapy Oncology Group Trial 9402, Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D et al (2006) Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24(18):2707–2714

    Google Scholar 

  4. Kyritsis AP, Yung WK, Bruner J, Gleason MJ, Levin VA (1993) The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 32(3):365–370

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Athanassios P. Kyritsis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kyritsis, A.P., Puduvalli, V.K. & Levin, V.A. Chemotherapy as first line treatment for oligodendroglioma. J Neurooncol 86, 361–362 (2008). https://doi.org/10.1007/s11060-007-9465-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-007-9465-5

Keywords

Navigation